| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.7 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |